Results from the MITHRAS trial reported at TCT Connect and published in Circulation
NEW YORK – October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance. Findings were reported today at TCT…
Details